Scripps Health and MD Anderson Cancer Center Announce Partnership to Create Clinically Integrated Cancer Program
Scripps Health and The University of Texas MD Anderson Cancer Center have reached a partnership agreement to create Scripps MD Anderson Cancer Center, a comprehensive and clinically integrated cancer care program in San Diego that will provide adult cancer patients greater access to the most advanced oncology care available throughout Southern California.
Through this partnership, Scripps MD Anderson is part of MD Anderson Cancer...
MD Anderson plans free Making Cancer History® Seminar in Atlanta
The University of Texas MD Anderson Cancer Center presents its Making Cancer History® Seminar, 11:30 a.m. to 1 p.m. Wednesday, Sept. 21 at...
Making Cancer History®: Free seminar heads to San Antonio Sept. 13
Cancer experts from The University of Texas MD Anderson Cancer Center will head to San Antonio Tuesday, Sept. 13 for the Making Cancer History...
MD Anderson hosts annual evening fun run benefiting melanoma research
The University of Texas MD Anderson Cancer Center and The AIM at Melanoma Foundation are proud to co-host the ninth annual AIM for the CURE Melanoma Walk and Fun Run to raise funds for melanoma research and promote awareness of skin cancer prevention. The event, scheduled for Saturday, September 17, at 6 p.m., is held at night to prevent excessive sun exposure.
The 5K non-certified run begins outside MD Anderson's Mays Clinic...
MD Anderson receives $19.1 million in CPRIT awards for research and recruitment
The University of Texas MD Anderson Cancer Center was awarded $19.1 million in research grants this week from the Cancer Prevention and Research...
Statement from Ronald A. DePinho, M.D., president, The University of Texas MD Anderson Cancer Center
Thanks to the leadership and dedication of Vice President Joe Biden, cancer has become a key priority in America. Through collaboration, innovation...
‘Bursts’ of chromosome changes fuel breast cancer tumor growth
As with most cancers, triple-negative breast cancer (TNBC) cells have abnormal amounts of chromosomes or DNA copy number aberrations (CNAs...
Making Cancer History®: Free seminar comes to Austin
The University of Texas MD Anderson Cancer Center brings its signature Making Cancer History® seminar to Austin, 11:30 a.m. to 1 p.m., Monday...
Moon Shots Program APOLLO project aims to expose cancer’s evasive action
A study that indicates how advanced melanoma responds to an immunotherapy, published in Cancer Discovery, demonstrates a revolutionary...
Immune analysis of on-treatment longitudinal biopsies predicts response to melanoma immunotherapy
Immune response measured in tumor biopsies during the course of early treatment predicts which melanoma patients will benefit from specific...
Living Legend luncheon to honor in Dallas
The 27th annual A Conversation With a Living Legend® in Dallas, Sept. 28 at the Hilton Anatole, will honor Kenneth H. Cooper, M.D., M.P.H....
MD Anderson named top-ranked cancer hospital in annual survey
The University of Texas MD Anderson Cancer Center again has ranked No. 1 for cancer care by U.S. News & World Report’s annual “Best Hospitals...